购物车
- 全部删除
- 您的购物车当前为空
Cenupatide acetate 是一种尿激酶纤溶酶原激活物受体 (uPAR) 抑制剂,用于治疗与细胞迁移改变相关的疾病,例如癌症。
Cenupatide acetate 是一种尿激酶纤溶酶原激活物受体 (uPAR) 抑制剂,用于治疗与细胞迁移改变相关的疾病,例如癌症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 565 | 现货 | |
2 mg | ¥ 823 | 现货 | |
5 mg | ¥ 1,170 | 现货 | |
10 mg | ¥ 1,950 | 现货 | |
25 mg | ¥ 3,520 | 现货 | |
50 mg | ¥ 4,970 | 现货 | |
100 mg | ¥ 7,230 | 现货 | |
500 mg | ¥ 14,300 | 现货 |
产品描述 | Cenupatide acetate is an urokinase plasminogen activator receptor (uPAR) inhibitor for treating disorders associated altered cell migration, such as cancer. |
体内活性 | Cenupatide通过抑制uPAR与甲酰肽受体(FPRs)的结合,在链脲佐菌素(STZ)诱导的大鼠糖尿病模型中改善肾损伤[1]。 |
别名 | Cenupatide acetate(1006388-38-0 Free base) |
分子量 | 677.8 |
分子式 | C30H51N11O7 |
Smiles | C[C@@](NC([C@H](CCCNC(N)=N)NC(C(C)(C)NC([C@@H](NC(C)=O)CCCNC(N)=N)=O)=O)=O)(C(N)=O)CC1=CC=CC=C1.CC(O)=O |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | H2O: 10 mg/mL (14.8 mM), Sonication is recommended. DMSO: 5 mg/mL (7.4 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO/H2O
H2O
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容